WellFish Tech and Bue Salmon renew partnership as Lutelandet development gets underway. WellFish Tech is renewing its partnership with Bue Salmon, the Norwegian land-based salmon producer. Bue Salmon has been a WellFish Tech customer since September 2025, using routine blood biomarker analysis at its pilot facility at Gjørøy Nord in Bulandet to generate the biological data needed to make production decisions ahead of challenges, and to identify which operational strategies are delivering results.
“When you are scaling a production model that has never been done at this size before, you cannot afford to be reactive,” says Knut Eikeland, CEO, Bue Salmon. “Blood biomarker analysis gives us the biological data we need to make the right calls before problems arise, and to understand which parts of our operation are actually performing. That kind of insight is going to be critical as we move into Lutelandet.”
“Renewing a partnership is always a meaningful signal,” says Charlie Granfelt, CEO, WellFish Tech. “It tells us the data is being used, and that it is making a difference. We are looking forward to continuing that work with Bue as they move into the next phase of their development.”
Bue Salmon is a company developing large-scale land-based salmon farming. The company was established in 2015 and operates a pilot facility in Bulandet with an annual production capacity of just under 2,000 tonnes. Bue is headquartered in Florø.
At Lutelandet, Bue is developing a significantly larger land-based grow-out facility, with a long-term target of a total annual production of approximately 50,000-60,000 tonnes of salmon.
About WellFish Tech
WellFish Tech is a data-led decision-support company rooted in fish-level biochemistry, providing predictive modelling for aquaculture. Headquartered in Paisley, Scotland, WellFish Tech currently employs 26 people, and operates in the United Kingdom and Ireland, Norway and Canada while supporting customers beyond those borders.